Norman Kier
Primary Care · Sacramento, CANPI 1952912131
Payments from drug & device makers
Across 96 payments — averaging $27.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$473
- Amgen$472
- Novo Nordisk$428
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$378
- Agios Pharmaceuticals, Inc.$184
- AbbVie$122
- plus $551 from 16 others
What the payments were for
- Food & beverage$2,608100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $473 |
| Amgen | 20 | $472 |
| Novo Nordisk | 12 | $428 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $378 |
| Agios Pharmaceuticals, Inc. | 3 | $184 |
| AbbVie | 6 | $122 |
| Pfizer | 3 | $59 |
| Sobi, Inc | 2 | $58 |
| Exact Sciences | 2 | $55 |
| Johnson & Johnson | 2 | $48 |
| Edwards Lifesciences | 2 | $46 |
| Shield Therapeutics Inc | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Sanofi Pasteur Inc. | 1 | $31 |
| Cipher Pharmaceuticals US LLC | 1 | $26 |
| Bayer | 1 | $23 |
| Merck | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Qiagen, LLC | 1 | $19 |
| GSK | 1 | $15 |
| Alk-abello, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,608 in reported general payments places this provider in the 85th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $24,561 |
| EliquisApixaban | 19 | $16,053 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $15,494 |
| JardianceEmpagliflozin | 14 | $12,719 |
| LinzessLinaclotide | 11 | $5,345 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 100 | $2,453 |
| BreynaBudesonide/Formoterol Fumarate | 14 | $2,137 |
| Naloxone Hcl | 40 | $2,069 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 74 | $1,822 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,066 |
| Atorvastatin Calcium | 124 | $864 |
| Lidocaine | 11 | $737 |
| Ventolin HfaAlbuterol Sulfate | 15 | $697 |
| Losartan Potassium | 90 | $623 |
| Gabapentin | 70 | $587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $428 | $24,56124 claims |
| PfizerEliquis | $59 | $16,05319 claims |
| GSKTrelegy Ellipta | $15 | $15,49415 claims |
| AbbVieLinzess | $122 | $5,34511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 706 primary care providers in California.
Other primary care in Sacramento
- Veronica RamirezSacramento$83K
- Rolando SantosSacramento$9K
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Tyson FieldstedBakersfield$65K
- Joann BallPalm Desert$56K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.